Rapid deterioration in quality of life during interleukin-2- and α-interferon-based home therapy of renal cell carcinoma is associated with a good outcome

We conducted a prospective quality-of-life analysis during outpatient immunotherapy in 22 patients with progressive metastatic renal cell carcinoma (RCC) treated with subcutaneous interferon-α2a and subcutaneous interleukin-2. Patients' quality of life was assessed by the European Organization...

Descripción completa

Detalles Bibliográficos
Autores principales: Atzpodien, J, Küchler, Th, Wandert, T, Reitz, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394211/
https://www.ncbi.nlm.nih.gov/pubmed/12838299
http://dx.doi.org/10.1038/sj.bjc.6600996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394211/
https://www.ncbi.nlm.nih.gov/pubmed/12838299
http://dx.doi.org/10.1038/sj.bjc.6600996

Ejemplares similares